HCA Healthcare Q2 Earnings Preview: Analysts Expect $6.32 EPS, $18.5B Revenue

HCA Healthcare is expected to report Q2 earnings of $6.32 per share, up from $5.50 per share in the year-ago period, and quarterly revenue of $18.5 billion, compared to $17.49 billion a year earlier. Analysts have revised their expectations, with Truist Securities raising its price target to $415 and B of A Securities downgrading the stock to Neutral with a price target of $410.

HCA Healthcare (HCA) is gearing up to release its second-quarter 2025 earnings report on July 25, with analysts expecting a robust performance. The consensus estimate for earnings per share (EPS) is $6.32, representing a notable 14.3% year-over-year increase from $5.50 [1]. The projected revenue for the quarter is $18.5 billion, up 5.8% from $17.49 billion in the same period last year [2].

Analysts have revised their price targets in anticipation of the earnings announcement. Truist Securities raised its price target to $415, while B of A Securities downgraded the stock to Neutral with a price target of $410 [3]. These revisions underscore the varying expectations among analysts regarding HCA's financial performance.

HCA Healthcare has a strong track record of outperforming EPS and revenue projections. Over the past several years, the company has exceeded EPS estimates 75% of the time and revenue forecasts 88% of the time [1]. This historical performance suggests that the company may once again deliver an impressive Q2 report.

The consensus recommendation from 27 brokerage firms is an "Outperform" rating, indicating strong investor confidence in HCA's market prospects [1]. The company's projected GF Value of $385.57 for the next year suggests a potential upside of 12.59% from the current price of $342.46 [1].

As HCA prepares to report its Q2 earnings, investors and analysts will closely monitor the company's performance. A positive earnings surprise could boost the stock's price, while failing to meet estimates might lead to a decline. The management's discussion during the earnings call will be crucial in determining the sustainability of any immediate price changes and future earnings expectations.

References:
[1] https://www.gurufocus.com/news/3002951/hca-healthcare-hca-prepares-for-q2-earnings-announcement
[2] https://site.financialmodelingprep.com/market-news/hca-healthcare-q2-2025-earnings-preview
[3] https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46624633/top-wall-street-forecasters-revamp-hca-healthcare-expectations-ahead-of-q2-earnings